Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage
eLife · 2026
DOI: 10.7554/elife.107256 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Joshua L Cherry. Beteiligte Einrichtung: Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: Heterozygote, Major Histocompatibility Complex, Genetic Variation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).
Abstract (Originalsprache)
Several theoretical studies have concluded that heterozygote advantage makes at most a minor contribution to MHC diversity. Siljestam and Rueffler (2024) recently presented models in which heterozygote advantage alone can lead to realistically high diversity. Here I argue that heterozygote advantage cannot by itself explain MHC diversity, and that its contribution to diversity is unlikely to be large in most species. I first show that the high diversity reported by Siljestam and Rueffler is so sensitive to parameter values that the underlying phenomenon cannot explain the widespread diversity of MHC genes. I then consider a fundamental problem with explaining MHC diversity by heterozygote advantage alone: selective forces that favored heterozygotes would lead to the evolution of haplotypes having much higher fitness when homozygous, diminishing or eliminating heterozygote advantage. Diversity maintained by another force, however, might bring about adaptation to the more common heterozygous state at the expense of homozygous fitness. Thus, substantial heterozygote advantage may arise as a consequence of MHC diversity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, United States.
ORCID-Profile: Joshua L Cherry
Zitieren
APA
Cherry, J. L. (2026). Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage. eLife. https://doi.org/10.7554/elife.107256
Vancouver
Cherry JL. Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage. eLife. 2026. doi:10.7554/elife.107256
BibTeX
@article{Cherry2026,
author = {Cherry, Joshua L},
title = {Heterozygote advantage cannot explain MHC diversity, but MHC diversity can explain heterozygote advantage},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.107256}
}
EUVIMED